Synergistic Inhibition of Synbiotic Cultures among Lactobacilli and Plant Extracts against Vaginal Discharge Causing Candida albicans .
Siriwoot SookkheePhadungkiat KhamnoiThanapat SastrarujiSathian BoonkumNitwara WikanWutigri NimlamoolPublished in: Nutrients (2024)
Vulvovaginal candidiasis (VVC) is the most common cause of vaginal discharge among women. The present study aimed to investigate the synergistic anticandidal effect of lactobacillus cultures supplemented with plant extracts. Among 600 isolates of lactic acid bacteria, 41 isolates exhibited inhibitory activity against Candida albicans ATCC10231. Six out of 41 cell-free supernatants demonstrated the most potent antibacterial and anticandidal activities. They also inhibited the clinical isolates of C. albicans, causing VVC and non- C. albicans . The synergistic effect between Lactobacillus crispatus 84/7 and Limosilactobacillus reuteri 89/4 was demonstrated by the lowest fractional inhibitory concentration index (FICI = 0.5). The synbiotic culture of bacterial combination, cultured with Jerusalem artichoke ( H. tuberosus ) extract, also exhibited the strongest inhibition against the tested C. albicans . Biofilm formation decreased after 12 h of incubation in the selected cell-free supernatants of this synbiotic culture. The anticandidal activity of crude extracts was lost after treatment with proteinase K and trypsin but not with heating conditions, suggesting that it may be a heat-stable substance. In conclusion, the combination of L. crispatus 84/7 and L. reuteri 89/4 with H. tuberosus may be a promising candidate for inhibiting Candida infection and biofilm formation, with the potential use as ingredients in vaginal biotherapeutic products.
Keyphrases
- candida albicans
- cell free
- biofilm formation
- lactic acid
- circulating tumor
- anti inflammatory
- cancer therapy
- genetic diversity
- polycystic ovary syndrome
- signaling pathway
- endothelial cells
- oxidative stress
- heat stress
- metabolic syndrome
- staphylococcus aureus
- pregnant women
- drug delivery
- cystic fibrosis
- silver nanoparticles
- adipose tissue